Analyst Ratings For Amphastar Pharmaceuticals (NASDAQ:AMPH)
Today, BMO Capital Markets reiterated its Hold rating on Amphastar Pharmaceuticals (NASDAQ:AMPH) with a price target of $16.00.
There are 1 hold rating, 5 buy ratings on the stock.
The current consensus rating on Amphastar Pharmaceuticals (NASDAQ:AMPH) is Buy (Score: 2.83) with a consensus target price of $20.17 per share, a potential 14.84% upside.
Some recent analyst ratings include
- 7/31/2017-BMO Capital Markets Reiterated Rating of Hold.
- 7/22/2017-Wells Fargo & Company Reiterated Rating of Buy.
- 3/14/2017-Raymond James Financial, Inc. was Downgraded by analysts at Raymond James Financial, Inc. from a “Strong-Buy ” rating to a ” Outperform” rating. They now have a $18.00 price target on the stock, up previously from $21.00 .
Recent Insider Trading Activity For Amphastar Pharmaceuticals (NASDAQ:AMPH)
Amphastar Pharmaceuticals (NASDAQ:AMPH) has insider ownership of 11.10% and institutional ownership of 44.72%.
- On 6/9/2017 Richard K Prins, Director, sold 10,000 with an average share price of $17.07 per share and the total transaction amounting to $170,700.00. View SEC Filing
- On 6/1/2017 Michael A Zasloff, Director, sold 15,000 with an average share price of $17.01 per share and the total transaction amounting to $255,150.00. View SEC Filing
- On 5/31/2017 Jason B Shandell, Director, sold 11,482 with an average share price of $16.92 per share and the total transaction amounting to $194,275.44. View SEC Filing
- On 5/11/2017 Richard K Prins, Director, sold 7,500 with an average share price of $15.43 per share and the total transaction amounting to $115,725.00. View SEC Filing
- On 1/3/2017 Floyd F Petersen, Director, sold 400 with an average share price of $18.61 per share and the total transaction amounting to $7,444.00. View SEC Filing
- On 12/15/2016 Diane G Gerst, EVP, sold 2,940 with an average share price of $20.51 per share and the total transaction amounting to $60,299.40. View SEC Filing
- On 12/5/2016 Rong Zhou, EVP, sold 61 with an average share price of $20.70 per share and the total transaction amounting to $1,262.70. View SEC Filing
Recent Trading Activity for Amphastar Pharmaceuticals (NASDAQ:AMPH)
Shares of Amphastar Pharmaceuticals closed the previous trading session at 17.56 up +0.27 1.56% with 118,700 shares trading hands.